Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis
Authors:
- Elena CsernokECElena Csernok
- Peter LamprechtPLPeter Lamprecht
- Wolfgang L GrossWGWolfgang L Gross
- 1 January 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 22 (1) , 43-48
Abstract
Drugs and infections may induce antineutrophil cytoplasmic antibodies (ANCA) and vasculitic manifestations mimicking ANCA-associated vasculitides (AAV) and mechanisms relevant in their pathogenesis. This review summarizes the most recent findings in this field. Drug-induced and infection-induced proteinase 3 (PR3)-ANCA and myeloperoxidase (MPO)-ANCA may be associated with a vasculitis clinically resembling AAV. Mechanisms relevant for the break of tolerance and induction of ANCA (e.g. danger signals, superantigens, neutrophil extracellular traps, protease-activated receptor-2, IL-17 cells) may be shared to some extent between drug-induced and infection-induced ANCA-positive vasculitis and AAV, especially with regard to the potential role of infection in Wegener's granulomatosis. Differences in immunopathology, clinical presentation, and functional aspects of ANCA help to distinguish drug-induced and infection-induced ANCA-positive vasculitis from AAV, and present new avenues for future research in this field. Medications and infections, which induce PR3-ANCA and MPO-ANCA, have to be considered in the differential diagnosis of primary AAV. Moreover, there is clinical and experimental evidence for an association between certain drugs and infections with ANCA-production. Analysis of ANCA-induction in such conditions also sheds new light on our understanding of immune mechanisms relevant in the break of tolerance and ANCA-production in AAV.Keywords
This publication has 39 references indexed in Scilit:
- Review article: Drug‐induced anti‐neutrophil cytoplasmic antibody‐associated vasculitisNephrology, 2009
- Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine‐induced midline destructive lesionsArthritis & Rheumatism, 2008
- Drug-induced vasculitisCurrent Opinion in Rheumatology, 2008
- Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case control studyNephrology Dialysis Transplantation, 2007
- Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitisClinical Immunology, 2005
- Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitidesArthritis Research & Therapy, 2005
- Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase moleculeClinical and Experimental Immunology, 2004
- Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapyBritish Journal of Dermatology, 2000
- Antineutrophil Cytoplasmic Autoantibodies Interact with Primary Granule Constituents on the Surface of Apoptotic Neutrophils in the Absence of Neutrophil PrimingJournal of Experimental Medicine, 1996
- Transformation of Lupus-Inducing Drugs to Cytotoxic Products by Activated NeutrophilsScience, 1994